Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Ciprofloxacin for Cutaneous Leishmaniasis
NCT06798402Phase 2Recruiting
- Sponsor
- Al-Mustafa University College
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciprofloxacin in cutaneous leishmaniasis (CL), sponsored by Al-Mustafa University College. Started Feb 2025; status: recruiting.
02
Drugs
ciprofloxacin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT06798402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798402.